Confusion around failure of deal to import possible COVID-19 vaccine

A Taiwanese biotechnology company that said last month it had been authorized by a German company to sell a prospective COVID-19 vaccine announced on Tuesday that it had failed to negotiate a distribution agreement with Taiwan's government, but the two sides offered conflicting explanations as to the reasons why.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)